Bladder – Bowel Institute Texas Named a Medtronic Center of Excellence for InterStim™ Therapy

(Isstories Editorial):- McKinney, Texas Dec 30, 2025 (Issuewire.com) – Bladder & Bowel Institute Texas (BBI Texas) has been officially recognized by Medtronic as a Center of Excellence (COE) for InterStim therapy, a designation that reflects the clinic’s commitment to advanced care, clinical expertise, and exceptional patient outcomes in the treatment of bladder and bowel disorders.

Medtronic presented the Center of Excellence plaque to BBI Director of Pelvic Health Dr. Esther Han, D.O., FACS, FACOS, during a presentation held at the BBI Texas facility located at 6045 Alma Rd, Suite 100, McKinney, TX 75070.

The Medtronic Center of Excellence designation is awarded to select practices that demonstrate excellence in the use of InterStim therapy, an advanced form of sacral neuromodulation used to treat conditions such as overactive bladder, urinary retention, and fecal incontinence. The recognition is based on clinical experience, patient outcomes, commitment to innovation, and adherence to best-in-class standards of care.

More on Isstories:

• Bladder – Bowel Institute Texas Named a Medtronic Center of Excellence for InterStim™ Therapy
• Tipping Point for a Hollow Earth by Ruth Leedy Carr:
• Nirav Pandya, CEO, Calls for Greater Focus on Execution, Skills, and Practical Leadership in Modern Business
• Outer Circle Foundation Announces New Board of Directors and Advisors
• Analysis of 125 MVP Projects Reveals Why 68% Fail After Launch

“This recognition is a reflection of our team’s dedication to providing thoughtful, patient-centered care using the most advanced therapies available,” said Dr. Han. “Being named a Medtronic Center of Excellence reinforces our mission to restore quality of life for patients struggling with bladder and bowel conditions, and I’m incredibly proud of the work being done here at BBI Texas.”

Since opening its doors to patients in June 2025, BBI Texas has quickly established itself as a leader in specialized pelvic health care in Texas. The McKinney facility received the Texas Ambulatory Surgery Center Society’s 2025 ASC Innovations of the Year Award in August and has now been named a Medtronic Center of Excellence for InterStim therapy. As Bladder & Bowel Institute’s first expansion beyond its flagship Harrison, Arkansas location, the rapid succession of these honors underscores the facility’s clinical excellence, innovation, and strong momentum in Texas.

“This milestone underscores the vision behind our expansion into Texas,” said BBI Medical Director Dr. Chris Taylor. “Dr. Han’s expertise, combined with our established model of comprehensive pelvic health care, has allowed BBI Texas to deliver exceptional outcomes from the very beginning. We are honored to see that commitment recognized by Medtronic.”

As a Medtronic Center of Excellence, Bladder & Bowel Institute Texas joins a select group of practices nationwide recognized for leadership in InterStim therapy and pelvic health innovation.

About Bladder & Bowel Institute

Bladder & Bowel Institute is the world’s leading provider of advanced therapies for bladder and bowel control problems.  With multiple locations across the U.S., BBI proudly serves patients across Arkansas, Texas, Missouri, Oklahoma, Kansas, Tennessee and beyond. BBI is a trusted leader in the field, offering compassionate care and proven solutions to help patients restore control, and reclaim their lives.

To learn more or to schedule an appointment at BBI Texas, visit www.bladderbowelinstitute.com or call (855) BBI-HELP

About Dr. Chris Taylor, Medical Director

Dr. Chris Taylor is an OBGYN and has been taking care of women’s health care needs for over 20 years. Dr. Taylor grew up in the small community of Russellville, Arkansas, completed medical school at University of Arkansas for Medical Sciences in Little Rock, and went on to complete his residency at one of the top ranked OBGYN programs in the country, the University of Mississippi Medical Center in Jackson, Mississippi.

After 25+ years of treating female bladder problems, Dr. Taylor has treated nearly 35,000 women, performed over 7,500 Sacral Nerve Stimulation Procedures, and is the #1 provider of this therapy in the entire world.

About Dr. Esther Han, Director of Pelvic Health
Dr. Esther Han is a board-certified reconstructive urologist with specialized fellowship training in Female Pelvic Medicine and Reconstructive Surgery (FPMRS). She completed her medical degree with honors at the Texas College of Osteopathic Medicine, followed by residency at Detroit Medical Center and fellowship at William Beaumont Hospital.

Dr. Han has served in leadership roles at Texas Urology Specialists and USMD’s Incontinence Center and has treated thousands of women with bladder control issues, pelvic organ prolapse, and pelvic pain. Known for her advanced expertise and compassionate care, Dr. Han brings a patient-centered approach to helping individuals regain control and quality of life.

About Overactive Bladder

Overactive bladder (OAB) significantly impacts quality of life and can negatively affect social activities, exercise and cause disruptive nighttime voiding.1,2 Many sufferers are frustrated and embarrassed and limit their lives socially, professionally, and personally.3 However, 45% don’t seek treatment and as many as seven in 10 stop using medications within six months due to intolerable side effects or unsatisfying results.4,5,6

Evidence points to OAB being caused by a miscommunication between the bladder and brain.7 Sacral neuromodulation, or gentle stimulation of the sacral nerves, is thought to normalize the brain-bladder communication pathway thereby restoring bladder function and alleviating symptoms. Restored function is defined as 50% reduction in dysfunctional voiding symptoms from baseline.

About Fecal Incontinence

Fecal incontinence (FI) is a distressing and disruptive chronic condition that is characterized by the inability to control bowel movements, which results in frequent accidents and leakage. People with FI report more depression and embarrassment, as well as lower quality of life compared to those without FI.8 Even though FI is treatable, 8.5 out of 10 adults haven’t even told their doctor about their FI.9

 ###

• Coyne, K. S., C. Payne, et al.. “The impact of urinary urgency and frequency on health-related quality of life in overactive bladder: results from a national community survey.” Value Health 2005;7(4): 455-463.
• Cartwright, R., S. Srikrishna, et al.. “Validity and reliability of patient selected goals as an outcome measure in overactive bladder.” Int Urogynecol J 2011;22(7): 841-847.
• Dmochowski RR, Newman DK. Impact of overactive bladder on women in the United States: results of a national survey. Current Medical Research and Opinion. 2007;23:65- 76
• Muller, N. “What Americans understand and how they are affected by bladder control problems: highlights of recent nationwide consumer research.” Urol Nurs 2005;25(2): 109- 115.
• Yu YF, Nichol MB, Yu AP, et al. Persistence and adherence of medications for chronic overactive bladder/urinary incontinence in the California Medicaid Program. Value in Health. 2005;8(4)495-505.
• Leede Research, “Views on OAB: A Study for the National Association of Continence.” December 16, 2015.
• Leng WW, Morrisroe SN. Sacral nerve stimulation for the overactive bladder. Urol Clin N Am. 2006;33:491-501.
• Rockwood TH, Church JM, Fleshman JW, et al. Fecal Incontinence Quality of Life Scale – Quality of life instrument for patients with fecal incontinence. Dis Colon Rectum. 2000;43:9-16
• Damon H, Guye O, Seigneurin A, et al. Prevalence of anal incontinence in adults and impact on quality-of-life. Gastroenterol Clin Biol. 2006;30(1):37-43.

This article was originally published by IssueWire. Read the original article here.